 
	 
	
	
	
	
			- 
				Info Patient
			
- 
					»
				Aktive Wirkstoffe
			
Aktive Wirkstoffe
	
		
					- 
						
							atezolizumab						
					
- 
						
							atidarsagene autotemcel						
					
- 
						
							atosiban (as acetate)						
					
- 
						
							attenuated feline panleucopenia virus (PLI IV)						
					
- 
						
							attenuated feline rhinotracheitis herpesvirus (FHV F2 strain), inactivated feline calicivirosis antigens (FCV 431 and G1 strains)						
					
- 
						
							attenuated feline rhinotracheitis herpesvirus (FHV F2 strain), inactivated feline calicivirosis antigens (FCV 431 and G1 strains), attenuated Chlamydophila felis (905 strain)						
					
- 
						
							attenuated feline rhinotracheitis herpesvirus (FHV F2 strain), inactivated feline calicivirosis antigens (FCV 431 and G1 strains), attenuated Chlamydophila felis (905 strain), attenuated feline panleucopenia virus (PLI IV)						
					
- 
						
							attenuated feline rhinotracheitis herpesvirus (FHV F2 strain), inactivated feline calicivirosis antigens (FCV 431 and G1 strains), attenuated feline panleucopenia virus (PLI IV), FeLV recombinant canarypox virus (vCP97)						
					
- 
						
							attenuated feline rhinotracheitis herpesvirus (FHV F2 strain), inactivated feline calicivirosis antigens (FCV 431 and G1 strains), attenuated feline panleucopenia virus (PLI IV), FeLV recombinant canarypox virus (vCP97), attenuated Chlamydophila felis 						
					
- 
						
							attenuated live rabies vaccine virus, strain SPBN GASGAS						
					
- 
						
							Autologous CD34+ cell enriched population that contains hematopoietic stem cells transduced with lentiglobin BB305 lentiviral vector encoding the beta-A-T87Q-globin gene						
					
- 
						
							autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human adenosine deaminase (ADA) cDNA sequence from human haematopoietic stem/progenitor (CD34+) cells						
					
- 
						
							autologous cultured chondrocytes						
					
- 
						
							autologous peripheral-blood mononuclear cells including a minimum of 50 million autologous CD54+ cells activated with prostatic acid phosphatase granulocyte-macrophage colony-stimulating factor						
					
- 
						
							Autologous peripheral blood T cells CD4 and CD8 selected and CD3 and CD28 activated transduced with retroviral vector expressing anti-CD19 CD28/CD3-zeta chimeric antigen receptor and cultured						
					
- 
						
							Avacopan						
					
- 
						
							avanafil						
					
- 
						
							avapritinib						
					
- 
						
							avatrombopag maleate						
					
- 
						
							avelumab